Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
Authors
Keywords
-
Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-18
DOI
10.1007/s10072-022-06447-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
- (2022) Alison Tarke et al. CELL
- Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada
- (2022) Ana Cecilia Ulloa et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination
- (2022) Maryam Golshani et al. Vaccines
- SARS-CoV-2 triggered relapse of multiple sclerosis
- (2022) Josef Finsterer CLINICAL NEUROLOGY AND NEUROSURGERY
- The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
- (2021) Angela Dziedzic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
- (2021) Anthony T. Reder et al. CNS DRUGS
- Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
- (2021) Saúl Reyes et al. JOURNAL OF NEUROIMMUNOLOGY
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
- (2021) Mahdi Barzegar et al. Multiple Sclerosis and Related Disorders
- Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
- (2021) Yu-Jing Fan et al. Vaccines
- Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves
- (2021) Caroline Maslo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
- (2021) Salim S Abdool Karim et al. LANCET
- Characteristics of COVID-19 in patients with multiple sclerosis
- (2021) Fereshteh Ghadiri et al. Multiple Sclerosis and Related Disorders
- ¿ Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis
- (2021) Gloria Michelena et al. Multiple Sclerosis and Related Disorders
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
- (2020) Allison J. Greaney et al. Cell Host & Microbe
- Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases
- (2020) Nora Möhn et al. Journal of Clinical Medicine
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- B cells in multiple sclerosis
- (2018) Mireia Sospedra CURRENT OPINION IN NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now